Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Accumulated Expenses (2020 - 2023)

Historic Other Accumulated Expenses for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $392000.0.

  • Terns Pharmaceuticals' Other Accumulated Expenses rose 2727.27% to $392000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $392000.0, marking a year-over-year increase of 2727.27%. This contributed to the annual value of $185000.0 for FY2022, which is 4832.4% down from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Other Accumulated Expenses stood at $392000.0, which was up 2727.27% from $280000.0 recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Other Accumulated Expenses peaked at $392000.0 during Q3 2023, and registered a low of $83000.0 during Q1 2021.
  • Its 4-year average for Other Accumulated Expenses is $230416.7, with a median of $228000.0 in 2022.
  • Over the last 5 years, Terns Pharmaceuticals' Other Accumulated Expenses had its largest YoY gain of 27108.43% in 2022, and its largest YoY loss of 4832.4% in 2022.
  • Over the past 4 years, Terns Pharmaceuticals' Other Accumulated Expenses (Quarter) stood at $162000.0 in 2020, then soared by 120.99% to $358000.0 in 2021, then tumbled by 48.32% to $185000.0 in 2022, then skyrocketed by 111.89% to $392000.0 in 2023.
  • Its Other Accumulated Expenses was $392000.0 in Q3 2023, compared to $280000.0 in Q2 2023 and $363000.0 in Q1 2023.